Lv1
30 积分 2023-05-22 加入
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
17小时前
待确认
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
17小时前
已完结
Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors
1个月前
已完结
The G Protein-First Mechanism for Activation of the Class B Glucagon-like Peptide 1 Receptor Coupled to N-Terminal Domain-Mediated Conformational Progression
1个月前
已完结
Structure and conformational variability of the HER2-trastuzumab-pertuzumab complex
2个月前
已完结
The present and future of bispecific antibodies for cancer therapy
3个月前
已完结
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
4个月前
已完结
The blood–tumour barrier in cancer biology and therapy
4个月前
已完结
Amivantamab plus chemotherapy vs chemotherapy as first-line treatment among patients with EGFR exon 20 insertion–mutated advanced non-small cell lung cancer (NSCLC): PAPILLON Chinese subgroup analysis
4个月前
已完结
Core element characterization of Rhodococcus promoters and development of a promoter-RBS mini-pool with different activity levels for efficient gene expression
4个月前
已完结
皖公网安备34019202002308
